Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The differences of hemogram, myelogram, and driver gene mutations in classic myeloproliferative neoplasms.

Blood cells, molecules & diseases - 1 Nov 2022

Wang Jin, Zhang Jin, Huang Jinjin, Mei Yu, Hong Zhenya

Abstract excerpt

The aim of this study was to explore and compare routine blood features and pathological characteristics of bone marrow tissues in essential thrombocythemia (ET), polycythemia vera (PV), primary myelofibrosis, prefibrotic stage (prePMF) and overt fibrotic stage (overtPMF), and the correlation between common driver gene mutations and clinical manifestations of myeloproliferative neoplasms (MPN). Methods: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Janus Kinase 2
Share to Mutation
Share to Myeloproliferative Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polycythemia Vera

Share to Primary Myelofibrosis

Share to Thrombocythemia, Essential

Source

Identifiers

PMID: 35914897
DOI: 10.1016/j.bcmd.2022.102698

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The differences of hemogram, myelogram, and driver gene mutations in classic myeloproliferative neoplasms.PMID 35914897Read ↗

Clinical features and next-generation sequencing landscape of essential thrombocythemia, prefibrotic primary myelofibrosis, and overt fibrotic primary myelofibrosis: a Chinese monocentric retrospective study.Semantic proximity Read ↗

Next-Generation Sequencing Mutational Landscape and Clinical Features of Chinese Adults with Myeloproliferative NeoplasmsSemantic proximity Read ↗

[Pathological characteristics of megakaryocytes in myeloproliferative neoplasms and their correlation with driver gene mutations].Semantic proximity Read ↗

Update from the latest WHO classification of MPNs: a user's manual.Semantic proximity Read ↗

[Research status and challenges of advanced myeloproliferative neoplasms].Semantic proximity Read ↗

Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis.Semantic proximity Read ↗

Prodromal myeloproliferative neoplasms: the 2008 WHO classification.Semantic proximity Read ↗

Recent advances in understanding myelofibrosis and essential thrombocythemiaSemantic proximity Read ↗

[CURRENT CRITERIA FOR THE DIAGNOSIS OF MYELOPROLIFERATIVE NEOPLASMS - WHAT IS IMPORTANT TO KNOW?]Semantic proximity Read ↗

The new WHO classification for essential thrombocythemia calls for revision of available evidences.Semantic proximity Read ↗

The 2014 BCSH criteria and the 2016 WHO criteria for essential thrombocythemia: A comparison in a large-scale cohort.Semantic proximity Read ↗

Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.